Comparison of Quercetin Pharmacokinetics Following Oral Supplementation in Humans
: The objective of the study was to investigate the absorption of quercetin aglycone in 18 healthy human subjects administered via the following oral carrier systems: suspension of quercetin (quercetin QU995 powder in Tang® and spring water), nutritional bars (First Strike™), and chews (RealFX™ Q‐P...
Gespeichert in:
| Veröffentlicht in: | Journal of food science 2012-11, Vol.77 (11), p.H231-H238 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | H238 |
|---|---|
| container_issue | 11 |
| container_start_page | H231 |
| container_title | Journal of food science |
| container_volume | 77 |
| creator | Kaushik, Diksha O'Fallon, Kevin Clarkson, Priscilla M. Patrick Dunne, C. Conca, Karen R. Michniak-Kohn, Bozena |
| description | : The objective of the study was to investigate the absorption of quercetin aglycone in 18 healthy human subjects administered via the following oral carrier systems: suspension of quercetin (quercetin QU995 powder in Tang® and spring water), nutritional bars (First Strike™), and chews (RealFX™ Q‐Plus™). Subjects were divided into 3 groups of 6 individuals each receiving 500 mg quercetin in one of the aforementioned formulations. Blood levels were monitored immediately pre‐ and for 32 h postadministration. The concentration of total quercetin in blood samples was determined by solid phase extraction followed by high‐performance liquid chromatography analysis. Pharmacokinetic parameters were determined by noncompartmental modeling using Kinetica software. The Cmax of quercetin was highest with RealFX™ Q‐Plus™ Chews (1051.9 ± 393.1 μg/L) achieved within 3.3 h as compared to that for First Strike™ Bars (698.1 ± 189.5 μg/L in 2.3 h) and Tang® suspension (354.4 ± 87.6 μg/L in 4.7 h). The results showed no statistically significant difference in quercetin absorption among groups due to high variability within groups receiving quercetin from same dosage form. This study represents the first comprehensive evaluation of quercetin absorption from quercetin fortified oral food products at doses commonly used for quercetin supplementation.
Practical Application: The current study describes for the first time, comprehensive evaluation of quercetin PK in humans from quercetin fortified oral food products at doses commonly used for quercetin supplementation. Owing to quercetin's potent antioxidant and anti‐inflammatory actions, quercetin is widely being used as a nutritional supplement. In order to maximize the bioavailability of quercetin for its use in efficacy studies, it is important to determine its ideal oral carrier system and route for its delivery. The current research unveils vital information about quercetin supplementation to the international community, especially to soldiers, athletes, and the dietary supplement industry. |
| doi_str_mv | 10.1111/j.1750-3841.2012.02934.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273337429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2829180291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5354-3eafa65b85c19804b8e7ba63467f81f3acfef2c8e98255cf7cc012cb29da23713</originalsourceid><addsrcrecordid>eNqNkUtP3DAUhS3UCobHX6giddNNUr9iO5tK1QwDrWgBAWrVjeUYGzwkcbATMfz7Oh06i26KN_aVv3Ou7j0AZAgWKJ2PqwLxEuZEUFRgiHABcUVosd4Bs-3HGzCDEOMcIcr3wH6MKzjVhO2CPUxgRSuKZuBy7tteBRd9l3mbXY4maDO4Lru4V6FV2j-4LtU6ZkvfNP7JdXfZeVBNdjX2fWNa0w1qcEmcJKdjq7p4CN5a1URz9HIfgJvl8fX8ND87P_ky_3yW65KUNCdGWcXKWpQaVQLSWhheK0Yo41YgS5S2xmItTCVwWWrLtU6D6hpXtwoTjsgB-LDx7YN_HE0cZOuiNk2jOuPHKBHmhBBO02b-jzLGUVoJTuj7f9CVH0OXBkkUhpVgQsBEiQ2lg48xGCv74FoVniWCckpIruQUhJyCkFNC8k9Ccp2k714ajHVrbrfCv5Ek4NMGeHKNeX61sfy6XFxNz2SQbwxcHMx6a6DCg2Sc8FL--H4iF4ufc_YLMfmN_AZi9q3F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1220986880</pqid></control><display><type>article</type><title>Comparison of Quercetin Pharmacokinetics Following Oral Supplementation in Humans</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kaushik, Diksha ; O'Fallon, Kevin ; Clarkson, Priscilla M. ; Patrick Dunne, C. ; Conca, Karen R. ; Michniak-Kohn, Bozena</creator><creatorcontrib>Kaushik, Diksha ; O'Fallon, Kevin ; Clarkson, Priscilla M. ; Patrick Dunne, C. ; Conca, Karen R. ; Michniak-Kohn, Bozena</creatorcontrib><description>: The objective of the study was to investigate the absorption of quercetin aglycone in 18 healthy human subjects administered via the following oral carrier systems: suspension of quercetin (quercetin QU995 powder in Tang® and spring water), nutritional bars (First Strike™), and chews (RealFX™ Q‐Plus™). Subjects were divided into 3 groups of 6 individuals each receiving 500 mg quercetin in one of the aforementioned formulations. Blood levels were monitored immediately pre‐ and for 32 h postadministration. The concentration of total quercetin in blood samples was determined by solid phase extraction followed by high‐performance liquid chromatography analysis. Pharmacokinetic parameters were determined by noncompartmental modeling using Kinetica software. The Cmax of quercetin was highest with RealFX™ Q‐Plus™ Chews (1051.9 ± 393.1 μg/L) achieved within 3.3 h as compared to that for First Strike™ Bars (698.1 ± 189.5 μg/L in 2.3 h) and Tang® suspension (354.4 ± 87.6 μg/L in 4.7 h). The results showed no statistically significant difference in quercetin absorption among groups due to high variability within groups receiving quercetin from same dosage form. This study represents the first comprehensive evaluation of quercetin absorption from quercetin fortified oral food products at doses commonly used for quercetin supplementation.
Practical Application: The current study describes for the first time, comprehensive evaluation of quercetin PK in humans from quercetin fortified oral food products at doses commonly used for quercetin supplementation. Owing to quercetin's potent antioxidant and anti‐inflammatory actions, quercetin is widely being used as a nutritional supplement. In order to maximize the bioavailability of quercetin for its use in efficacy studies, it is important to determine its ideal oral carrier system and route for its delivery. The current research unveils vital information about quercetin supplementation to the international community, especially to soldiers, athletes, and the dietary supplement industry.</description><identifier>ISSN: 0022-1147</identifier><identifier>EISSN: 1750-3841</identifier><identifier>DOI: 10.1111/j.1750-3841.2012.02934.x</identifier><identifier>PMID: 23094941</identifier><identifier>CODEN: JFDSAZ</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Administration, Oral ; Adolescent ; Adult ; Antioxidants - administration & dosage ; Antioxidants - pharmacokinetics ; Area Under Curve ; AUC ; Bars ; Biological Availability ; Blood ; buccal ; Calibration ; Carriers ; Chromatography ; Chromatography, High Pressure Liquid ; Cmax ; Comparative analysis ; Dietary Supplements ; Female ; Food products ; Food science ; Foods ; Fortified ; Human ; Humans ; Male ; Mathematical models ; Nutrition ; oral ; Powders - chemistry ; quercetin ; Quercetin - administration & dosage ; Quercetin - blood ; Quercetin - pharmacokinetics ; Receiving ; Young Adult</subject><ispartof>Journal of food science, 2012-11, Vol.77 (11), p.H231-H238</ispartof><rights>2012 Institute of Food Technologists</rights><rights>Copyright Institute of Food Technologists Nov 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5354-3eafa65b85c19804b8e7ba63467f81f3acfef2c8e98255cf7cc012cb29da23713</citedby><cites>FETCH-LOGICAL-c5354-3eafa65b85c19804b8e7ba63467f81f3acfef2c8e98255cf7cc012cb29da23713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1750-3841.2012.02934.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1750-3841.2012.02934.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27911,27912,45561,45562</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23094941$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaushik, Diksha</creatorcontrib><creatorcontrib>O'Fallon, Kevin</creatorcontrib><creatorcontrib>Clarkson, Priscilla M.</creatorcontrib><creatorcontrib>Patrick Dunne, C.</creatorcontrib><creatorcontrib>Conca, Karen R.</creatorcontrib><creatorcontrib>Michniak-Kohn, Bozena</creatorcontrib><title>Comparison of Quercetin Pharmacokinetics Following Oral Supplementation in Humans</title><title>Journal of food science</title><addtitle>J Food Sci</addtitle><description>: The objective of the study was to investigate the absorption of quercetin aglycone in 18 healthy human subjects administered via the following oral carrier systems: suspension of quercetin (quercetin QU995 powder in Tang® and spring water), nutritional bars (First Strike™), and chews (RealFX™ Q‐Plus™). Subjects were divided into 3 groups of 6 individuals each receiving 500 mg quercetin in one of the aforementioned formulations. Blood levels were monitored immediately pre‐ and for 32 h postadministration. The concentration of total quercetin in blood samples was determined by solid phase extraction followed by high‐performance liquid chromatography analysis. Pharmacokinetic parameters were determined by noncompartmental modeling using Kinetica software. The Cmax of quercetin was highest with RealFX™ Q‐Plus™ Chews (1051.9 ± 393.1 μg/L) achieved within 3.3 h as compared to that for First Strike™ Bars (698.1 ± 189.5 μg/L in 2.3 h) and Tang® suspension (354.4 ± 87.6 μg/L in 4.7 h). The results showed no statistically significant difference in quercetin absorption among groups due to high variability within groups receiving quercetin from same dosage form. This study represents the first comprehensive evaluation of quercetin absorption from quercetin fortified oral food products at doses commonly used for quercetin supplementation.
Practical Application: The current study describes for the first time, comprehensive evaluation of quercetin PK in humans from quercetin fortified oral food products at doses commonly used for quercetin supplementation. Owing to quercetin's potent antioxidant and anti‐inflammatory actions, quercetin is widely being used as a nutritional supplement. In order to maximize the bioavailability of quercetin for its use in efficacy studies, it is important to determine its ideal oral carrier system and route for its delivery. The current research unveils vital information about quercetin supplementation to the international community, especially to soldiers, athletes, and the dietary supplement industry.</description><subject>Administration, Oral</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Antioxidants - administration & dosage</subject><subject>Antioxidants - pharmacokinetics</subject><subject>Area Under Curve</subject><subject>AUC</subject><subject>Bars</subject><subject>Biological Availability</subject><subject>Blood</subject><subject>buccal</subject><subject>Calibration</subject><subject>Carriers</subject><subject>Chromatography</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cmax</subject><subject>Comparative analysis</subject><subject>Dietary Supplements</subject><subject>Female</subject><subject>Food products</subject><subject>Food science</subject><subject>Foods</subject><subject>Fortified</subject><subject>Human</subject><subject>Humans</subject><subject>Male</subject><subject>Mathematical models</subject><subject>Nutrition</subject><subject>oral</subject><subject>Powders - chemistry</subject><subject>quercetin</subject><subject>Quercetin - administration & dosage</subject><subject>Quercetin - blood</subject><subject>Quercetin - pharmacokinetics</subject><subject>Receiving</subject><subject>Young Adult</subject><issn>0022-1147</issn><issn>1750-3841</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtP3DAUhS3UCobHX6giddNNUr9iO5tK1QwDrWgBAWrVjeUYGzwkcbATMfz7Oh06i26KN_aVv3Ou7j0AZAgWKJ2PqwLxEuZEUFRgiHABcUVosd4Bs-3HGzCDEOMcIcr3wH6MKzjVhO2CPUxgRSuKZuBy7tteBRd9l3mbXY4maDO4Lru4V6FV2j-4LtU6ZkvfNP7JdXfZeVBNdjX2fWNa0w1qcEmcJKdjq7p4CN5a1URz9HIfgJvl8fX8ND87P_ky_3yW65KUNCdGWcXKWpQaVQLSWhheK0Yo41YgS5S2xmItTCVwWWrLtU6D6hpXtwoTjsgB-LDx7YN_HE0cZOuiNk2jOuPHKBHmhBBO02b-jzLGUVoJTuj7f9CVH0OXBkkUhpVgQsBEiQ2lg48xGCv74FoVniWCckpIruQUhJyCkFNC8k9Ccp2k714ajHVrbrfCv5Ek4NMGeHKNeX61sfy6XFxNz2SQbwxcHMx6a6DCg2Sc8FL--H4iF4ufc_YLMfmN_AZi9q3F</recordid><startdate>201211</startdate><enddate>201211</enddate><creator>Kaushik, Diksha</creator><creator>O'Fallon, Kevin</creator><creator>Clarkson, Priscilla M.</creator><creator>Patrick Dunne, C.</creator><creator>Conca, Karen R.</creator><creator>Michniak-Kohn, Bozena</creator><general>Blackwell Publishing Inc</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7ST</scope><scope>7T7</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope></search><sort><creationdate>201211</creationdate><title>Comparison of Quercetin Pharmacokinetics Following Oral Supplementation in Humans</title><author>Kaushik, Diksha ; O'Fallon, Kevin ; Clarkson, Priscilla M. ; Patrick Dunne, C. ; Conca, Karen R. ; Michniak-Kohn, Bozena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5354-3eafa65b85c19804b8e7ba63467f81f3acfef2c8e98255cf7cc012cb29da23713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Administration, Oral</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Antioxidants - administration & dosage</topic><topic>Antioxidants - pharmacokinetics</topic><topic>Area Under Curve</topic><topic>AUC</topic><topic>Bars</topic><topic>Biological Availability</topic><topic>Blood</topic><topic>buccal</topic><topic>Calibration</topic><topic>Carriers</topic><topic>Chromatography</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cmax</topic><topic>Comparative analysis</topic><topic>Dietary Supplements</topic><topic>Female</topic><topic>Food products</topic><topic>Food science</topic><topic>Foods</topic><topic>Fortified</topic><topic>Human</topic><topic>Humans</topic><topic>Male</topic><topic>Mathematical models</topic><topic>Nutrition</topic><topic>oral</topic><topic>Powders - chemistry</topic><topic>quercetin</topic><topic>Quercetin - administration & dosage</topic><topic>Quercetin - blood</topic><topic>Quercetin - pharmacokinetics</topic><topic>Receiving</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaushik, Diksha</creatorcontrib><creatorcontrib>O'Fallon, Kevin</creatorcontrib><creatorcontrib>Clarkson, Priscilla M.</creatorcontrib><creatorcontrib>Patrick Dunne, C.</creatorcontrib><creatorcontrib>Conca, Karen R.</creatorcontrib><creatorcontrib>Michniak-Kohn, Bozena</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Environment Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of food science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaushik, Diksha</au><au>O'Fallon, Kevin</au><au>Clarkson, Priscilla M.</au><au>Patrick Dunne, C.</au><au>Conca, Karen R.</au><au>Michniak-Kohn, Bozena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Quercetin Pharmacokinetics Following Oral Supplementation in Humans</atitle><jtitle>Journal of food science</jtitle><addtitle>J Food Sci</addtitle><date>2012-11</date><risdate>2012</risdate><volume>77</volume><issue>11</issue><spage>H231</spage><epage>H238</epage><pages>H231-H238</pages><issn>0022-1147</issn><eissn>1750-3841</eissn><coden>JFDSAZ</coden><abstract>: The objective of the study was to investigate the absorption of quercetin aglycone in 18 healthy human subjects administered via the following oral carrier systems: suspension of quercetin (quercetin QU995 powder in Tang® and spring water), nutritional bars (First Strike™), and chews (RealFX™ Q‐Plus™). Subjects were divided into 3 groups of 6 individuals each receiving 500 mg quercetin in one of the aforementioned formulations. Blood levels were monitored immediately pre‐ and for 32 h postadministration. The concentration of total quercetin in blood samples was determined by solid phase extraction followed by high‐performance liquid chromatography analysis. Pharmacokinetic parameters were determined by noncompartmental modeling using Kinetica software. The Cmax of quercetin was highest with RealFX™ Q‐Plus™ Chews (1051.9 ± 393.1 μg/L) achieved within 3.3 h as compared to that for First Strike™ Bars (698.1 ± 189.5 μg/L in 2.3 h) and Tang® suspension (354.4 ± 87.6 μg/L in 4.7 h). The results showed no statistically significant difference in quercetin absorption among groups due to high variability within groups receiving quercetin from same dosage form. This study represents the first comprehensive evaluation of quercetin absorption from quercetin fortified oral food products at doses commonly used for quercetin supplementation.
Practical Application: The current study describes for the first time, comprehensive evaluation of quercetin PK in humans from quercetin fortified oral food products at doses commonly used for quercetin supplementation. Owing to quercetin's potent antioxidant and anti‐inflammatory actions, quercetin is widely being used as a nutritional supplement. In order to maximize the bioavailability of quercetin for its use in efficacy studies, it is important to determine its ideal oral carrier system and route for its delivery. The current research unveils vital information about quercetin supplementation to the international community, especially to soldiers, athletes, and the dietary supplement industry.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>23094941</pmid><doi>10.1111/j.1750-3841.2012.02934.x</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-1147 |
| ispartof | Journal of food science, 2012-11, Vol.77 (11), p.H231-H238 |
| issn | 0022-1147 1750-3841 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1273337429 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Administration, Oral Adolescent Adult Antioxidants - administration & dosage Antioxidants - pharmacokinetics Area Under Curve AUC Bars Biological Availability Blood buccal Calibration Carriers Chromatography Chromatography, High Pressure Liquid Cmax Comparative analysis Dietary Supplements Female Food products Food science Foods Fortified Human Humans Male Mathematical models Nutrition oral Powders - chemistry quercetin Quercetin - administration & dosage Quercetin - blood Quercetin - pharmacokinetics Receiving Young Adult |
| title | Comparison of Quercetin Pharmacokinetics Following Oral Supplementation in Humans |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T03%3A31%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Quercetin%20Pharmacokinetics%20Following%20Oral%20Supplementation%20in%20Humans&rft.jtitle=Journal%20of%20food%20science&rft.au=Kaushik,%20Diksha&rft.date=2012-11&rft.volume=77&rft.issue=11&rft.spage=H231&rft.epage=H238&rft.pages=H231-H238&rft.issn=0022-1147&rft.eissn=1750-3841&rft.coden=JFDSAZ&rft_id=info:doi/10.1111/j.1750-3841.2012.02934.x&rft_dat=%3Cproquest_cross%3E2829180291%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1220986880&rft_id=info:pmid/23094941&rfr_iscdi=true |